Publisher
Springer Berlin Heidelberg
Reference26 articles.
1. Amin KA, Sah PK, Hulse S, Shellock FG, Swan HC (1984) Myocardial metabolic and hemodynamic effects of intravenous MDL 117043, a new cardiotonic drug, in patients with chronic severe heart failure. Am Heart J 108: 1285–1292
2. Appleman MM, Beavo JA Jr, Hardman JG, Klee CB, Thompson WJ (1984) A subcommittee for nomenclature recommendations. Adv Cyclic Nucleotide Protein Phosphorylation Res 16: VI
3. Bairn DS (1989) Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow. Am J Cardiol 63: 23A - 26A
4. Boldt J, Kling D, Schuhmann E, Scheld DD, Hempelmann G (1988) Der neue Phosphodiesterase-Hemmer Enoximone im Rahmen herzchirurgischer Eingriffe–Eine vergleichende Untersuchung zu Dobutamin. Herz 13: 335–342
5. Boldt J, Kling D, Moosdorf R, Hempelmann G (1990) Enoximone treatment of impaired myocardial function during cardiac surgery: Combined effects with epinephrine. J Cardiothorac Anesth 4: 462–468